Rhapsogen

Rhapsogen

Pre-clinical
Cambridge, United StatesFounded 2020rhapsogen.com

Rhapsogen is developing a best in class precision biologic for autoimmune disease with superior efficacy, safety and durability.

Market Cap
Private
Pipeline
Patents
Publications

Private Company

Funding information not available

About

Rhapsogen is developing a best in class precision biologic for autoimmune disease with superior efficacy, safety and durability.

OncologySmall Molecules